Two judges in the U.S. District Court for the District of New Jersey have denied motions to dismiss for personal jurisdiction in Hatch-Waxman litigations based on the defendants’ compliance with New Jersey’s foreign...more
7/29/2015
/ Abbreviated New Drug Application (ANDA) ,
Boehringer ,
Compliance ,
Corporate Counsel ,
DaimlerAG ,
DaimlerChrysler v Bauman ,
Food and Drug Administration (FDA) ,
Foreign Corporations ,
Generic Drugs ,
Goodyear ,
Hatch-Waxman ,
Licensing Rules ,
Mylan Pharmaceuticals ,
Otsuka Pharmaceutical ,
Out-of-State Companies ,
Personal Jurisdiction ,
Pharmaceutical Industry ,
Pharmaceutical Patents ,
Popular ,
Prescription Drugs ,
Registration Requirement ,
SCOTUS ,
Teva Pharmaceuticals